Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
European Journal of Pediatrics
|
July 6, 2026
Disease severity of children with hereditary spherocytosis predicts the clinical course of aplastic crisis
Shiri Rubin, Shira Devora Ben Ami, Ohad Atia, et al.
The Lancet. Gastroenterology & Hepatology
|
January 9, 2025
Maintenance treatment with vedolizumab in paediatric inflammatory bowel disease (VEDOKIDS): 54-week outcomes of a multicentre, prospective, cohort study
Ohad Atia, Zivia Shavit-Brunschwig, Raffi Lev-Tzion, et al.
Journal of Crohn'S & Colitis
|
January 12, 2022
Existing Prediction Models of Disease Course in Paediatric Crohn's Disease Are Poorly Replicated in a Prospective Inception Cohort
Ohad Atia, Ben Kang, Esther Orlansky-Meyer, et al.
Inflammatory Bowel Diseases
|
February 8, 2024
Predictors of Complicated Disease Course in Adults and Children With Crohn's Disease: A Nationwide Study from the epi-IIRN
Ohad Atia, Rona Lujan, Rachel Buchuk, et al.
Journal of Crohn'S & Colitis
|
September 19, 2025
Validation of prediction models for anti-tumor necrosis factor treatment response in pediatric Crohn's disease: a systematic review and prospective cohort study
Omer Rotem-Tryfus, Ben Kang, Esther Orlanski-Meyer, et al.
The Lancet. Gastroenterology & Hepatology
|
October 28, 2022
Outcomes, dosing, and predictors of vedolizumab treatment in children with inflammatory bowel disease (VEDOKIDS): a prospective, multicentre cohort study
Ohad Atia, Zivia Shavit-Brunschwig, Diane R Mould, et al.
Inflammatory Bowel Diseases
|
May 20, 2024
Predictors of Complicated Disease Course in Children and Adults With Ulcerative Colitis: A Nationwide Study From the epi-IIRN
Ohad Atia, Rachel Buchuk, Rona Lujan, et al.
Alimentary Pharmacology & Therapeutics
|
June 23, 2022
Children included in randomised controlled trials of biologics in inflammatory bowel diseases do not represent the real-world patient mix
Ohad Atia, Gemma Pujol-Muncunill, Víctor Manuel Navas-López, et al.
Journal of Crohn'S & Colitis
|
November 18, 2021
Improved Outcomes of Paediatric and Adult Crohn's Disease and Association With Emerging Use of Biologics-A Nationwide Study From the Epi-IIRN
Ohad Atia, Esther Orlanski-Meyer, Rona Lujan, et al.
Crohn'S & Colitis 360
|
February 13, 2023
Development and Validation of the IBD-REFER Criteria: Early Referral for Suspected Inflammatory Bowel Diseases in Adults and Children
Ohad Atia, Adi Shosberger, Gili Focht, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
European Journal of Pediatrics
|
July 6, 2026
Disease severity of children with hereditary spherocytosis predicts the clinical course of aplastic crisis
Shiri Rubin, Shira Devora Ben Ami, Ohad Atia, et al.
The Lancet. Gastroenterology & Hepatology
|
January 9, 2025
Maintenance treatment with vedolizumab in paediatric inflammatory bowel disease (VEDOKIDS): 54-week outcomes of a multicentre, prospective, cohort study
Ohad Atia, Zivia Shavit-Brunschwig, Raffi Lev-Tzion, et al.
Journal of Crohn'S & Colitis
|
January 12, 2022
Existing Prediction Models of Disease Course in Paediatric Crohn's Disease Are Poorly Replicated in a Prospective Inception Cohort
Ohad Atia, Ben Kang, Esther Orlansky-Meyer, et al.
Inflammatory Bowel Diseases
|
February 8, 2024
Predictors of Complicated Disease Course in Adults and Children With Crohn's Disease: A Nationwide Study from the epi-IIRN
Ohad Atia, Rona Lujan, Rachel Buchuk, et al.
Journal of Crohn'S & Colitis
|
September 19, 2025
Validation of prediction models for anti-tumor necrosis factor treatment response in pediatric Crohn's disease: a systematic review and prospective cohort study
Omer Rotem-Tryfus, Ben Kang, Esther Orlanski-Meyer, et al.
The Lancet. Gastroenterology & Hepatology
|
October 28, 2022
Outcomes, dosing, and predictors of vedolizumab treatment in children with inflammatory bowel disease (VEDOKIDS): a prospective, multicentre cohort study
Ohad Atia, Zivia Shavit-Brunschwig, Diane R Mould, et al.
Inflammatory Bowel Diseases
|
May 20, 2024
Predictors of Complicated Disease Course in Children and Adults With Ulcerative Colitis: A Nationwide Study From the epi-IIRN
Ohad Atia, Rachel Buchuk, Rona Lujan, et al.
Alimentary Pharmacology & Therapeutics
|
June 23, 2022
Children included in randomised controlled trials of biologics in inflammatory bowel diseases do not represent the real-world patient mix
Ohad Atia, Gemma Pujol-Muncunill, Víctor Manuel Navas-López, et al.
Journal of Crohn'S & Colitis
|
November 18, 2021
Improved Outcomes of Paediatric and Adult Crohn's Disease and Association With Emerging Use of Biologics-A Nationwide Study From the Epi-IIRN
Ohad Atia, Esther Orlanski-Meyer, Rona Lujan, et al.
Crohn'S & Colitis 360
|
February 13, 2023
Development and Validation of the IBD-REFER Criteria: Early Referral for Suspected Inflammatory Bowel Diseases in Adults and Children
Ohad Atia, Adi Shosberger, Gili Focht, et al.
Page
of 4